CI - Cigna Corporation
NEXT EARNINGS:
May 1, 2026
EPS Est: $7.50
|
Rev Est: $67.0B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$325.83
DETAILS
HIGH:
$375.00
LOW:
$300.00
MEDIAN:
$321.50
CONSENSUS:
$325.83
UPSIDE:
15.95%
Market Cap:
75.06B
Volume:
1,452,480
Avg Volume:
1,650,133
52 Week Range:
239.51-350
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Beta:
0.28
Last Dividend:
$6.04
Exchange:
NYSE
Country:
US
Employees:
71,295
IPO Date:
1982-03-31
EPS (TTM):
22.30
P/E Ratio:
12.29
Revenue (TTM):
274.95B
Total Assets:
155.88B
Total Debt:
31.97B
Cash & Equiv:
7.55B
Rev Growth (5Y):
11.4%
EPS Growth (5Y):
-0.8%
FCF Growth (5Y):
1.2%
ROCE:
9.7%
Debt/Equity:
0.78
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $8.08 | $7.88 | +2.5% | $72.5B | $70.3B | +3.1% |
| 2025-10-30 | $7.83 | $7.64 | +2.5% | $69.7B | $67.6B | +3.2% |
| 2025-07-31 | $7.20 | $7.16 | +0.6% | $67.2B | $62.9B | +6.9% |
| 2025-05-02 | $6.74 | $6.35 | +6.1% | $65.5B | $60.2B | +8.8% |
| 2025-01-30 | $6.64 | $7.84 | -15.3% | $65.7B | $63.4B | +3.6% |
| 2024-10-31 | $7.51 | $7.23 | +3.9% | $62.8B | $59.5B | +5.6% |
| 2024-08-01 | $6.72 | $6.41 | +4.8% | $60.5B | $58.3B | +3.8% |
| 2024-05-02 | $6.47 | $6.22 | +4.0% | $55.4B | $56.5B | -2.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 274.95B | 247.12B | 195.26B | 180.52B | 174.07B | 160.40B | 153.57B | 48.65B | 41.81B | 39.84B | 37.88B | 34.91B |
| Net Income | 5.96B | 3.43B | 5.16B | 6.70B | 5.37B | 8.46B | 5.10B | 2.64B | 2.24B | 1.87B | 2.09B | 2.10B |
| EPS | 22.30 | 12.25 | 17.57 | 21.66 | 15.89 | 23.17 | 13.58 | 10.69 | 9.17 | 7.31 | 8.17 | 7.97 |
| Total Assets | N/A | 155.88B | 152.76B | 143.88B | 154.89B | 155.45B | 155.77B | 153.23B | 61.76B | 59.36B | 57.09B | 55.87B |
| Total Debt | N/A | 31.97B | 30.93B | 31.55B | 34.27B | 33.56B | 38.04B | 42.48B | 5.44B | 5.03B | 5.17B | 5.13B |
| Cash & Equivalents | N/A | 7.55B | 7.82B | 5.92B | 5.08B | 10.18B | 4.62B | 3.85B | 2.97B | 3.19B | 1.97B | 1.42B |
| Operating Cash Flow | N/A | 10.36B | 11.81B | 8.66B | 7.19B | 10.35B | 9.48B | 3.77B | 4.09B | 4.03B | 2.72B | 1.99B |
| Free Cash Flow | N/A | 8.96B | 10.24B | 7.36B | 6.04B | 9.26B | 8.44B | 3.24B | 3.62B | 3.56B | 2.21B | 1.52B |
| FCF per Share | N/A | 31.96 | 34.49 | 23.51 | 17.86 | 25.36 | 22.44 | 13.14 | 14.82 | 13.96 | 8.62 | 5.76 |
| Book Value | N/A | 41.03B | 46.22B | 44.87B | 47.11B | 50.32B | 45.34B | 41.03B | 13.73B | 13.72B | 12.04B | 10.77B |
| Cash & ST Investments | N/A | 8.21B | 8.75B | 6.83B | 6.00B | 11.51B | 5.56B | 5.90B | 3.17B | 3.88B | 2.35B | 1.58B |
| ROC Equity | N/A | 0.08 | 0.11 | 0.15 | 0.11 | 0.17 | 0.11 | 0.06 | 0.16 | 0.14 | 0.17 | 0.20 |